Company Getein Biotech, Inc

Equities

603387

CNE100002RR9

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
9.04 ^CNY	+0.44%		+4.75%	-17.82%

2023	Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
2023	Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Getein Biotech Inc is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and instruments. Its in vitro diagnostic reagents include Point-of-care Testing (POCT) reagents, chemiluminescence reagents, biochemical reagents, blood cell reagents, hemagglutination reagents and others. Its diagnostic instruments include immunoquantitative analyzer FIA 8000, immunoquantitative analyzer FIA 8600, fluorescence immunoquantitative analyzer Getein 1100, fluorescence immunoquantitative analyzer Getein 1180, automatic biochemical analyzer CM 400, automatic chemiluminescence analyzer MAGICL 6000 and five classification blood cell analyzer BHA-5000, among others. The Company also provides testing and agency services. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 2,508

CNY in Million	2021	Weight	2022	Weight	Delta
In Vitro Diagnosis 99.7 %	1,070	76.4 %	1,816	99.7 %	+69.64%
Other 0.3 %	4	0.3 %	6	0.3 %	+70.77%

CNY in Million	2021	Weight	2022	Weight	Delta
China 62.5 %	1,046	74.8 %	1,138	62.5 %	+8.86%
Foreign 37.5 %	352	25.2 %	684	37.5 %	+93.94%

Managers	Title	Age	Since
En Ben Su CEO	Chief Executive Officer	58	02-03-07
Wen Ni DFI	Director of Finance/CFO	41	12-12-31
Gang Zhu BRD	Director/Board Member	38	11-12-31
Ting Ting Kong BRD	Director/Board Member	40	08-04-30
Bin Yan BRD	Director/Board Member	42	09-12-31
Yu Xin Xie IRC	Investor Relations Contact	30	21-12-31
Cong Liu SEC	Corporate Secretary	-	19-04-24

Members of the board	Title	Age	Since
Jing Luo BRD	Director/Board Member	62	22-09-15
En Ben Su CEO	Chief Executive Officer	58	02-03-07
Bin Yan BRD	Director/Board Member	42	09-12-31
En Kui Su BRD	Director/Board Member	62	01-12-31
Ting Ting Kong BRD	Director/Board Member	40	08-04-30
Jing Li CHM	Chairman	42	08-12-31
Ai Di Tao BRD	Director/Board Member	54	20-12-17
Hong Hai Yu BRD	Director/Board Member	46	20-12-17
Qian Qian Lin BRD	Director/Board Member	31	14-12-31
Gang Zhu BRD	Director/Board Member	38	11-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	507,153,517	266,858,108 ( 52.62 %)	0	52.62 %

Name	Equities	%	Valuation
En Ben Su 43.23 %	219,218,114	43.23 %	279 M ¥
GF Fund Management Co., Ltd. 2.301 %	11,668,533	2.301 %	15 M ¥
Huatai Zijin Investment Co., Ltd. 1.465 %	7,431,406	1.465 %	9 M ¥
Aeon Life Insurance Co., Ltd. 1.424 %	7,220,798	1.424 %	9 M ¥
Guo Yu Huang 0.9030 %	4,579,597	0.9030 %	6 M ¥
Liang Jun Sun 0.8986 %	4,557,501	0.8986 %	6 M ¥
En Kui Su 0.8475 %	4,298,283	0.8475 %	5 M ¥
Xing De Xu 0.7370 %	3,737,595	0.7370 %	5 M ¥
Morgan Stanley Huaxin Fund Management Co., Ltd. 0.5016 %	2,543,740	0.5016 %	3 M ¥
Maxwealth Fund Management Co., Ltd. 0.1986 %	1,007,072	0.1986 %	1 M ¥

Getein Biotech, Inc.

9 Bofu Road Yanjiang Industrial Dev Zone

211505, Nanjing

+86 25 6856 8588

http://www.bio-gp.com.cn

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
GETEIN BIOTECH, INC	-17.82%	633M
BIOMÉRIEUX	+0.89%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
10X GENOMICS, INC.	-50.70%	3.3B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
VITROLIFE AB	-16.13%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B
MYRIAD GENETICS, INC.	-5.02%	1.64B

Diagnostic & Testing Substances